Li-Fraumeni Syndrome Cancer Surveillance Strategy Considerations for Glioblastoma Multiforme-Reference-Cited by-同舟云学术

Li-Fraumeni Syndrome Cancer Surveillance Strategy Considerations for Glioblastoma Multiforme

Published:2023-11-30 Issue:1 Volume:7 Page:10-13
ISSN:2582-0370
Container-title:Asploro Journal of Biomedical and Clinical Case Reports
language:en
Short-container-title:Asp Biomed Clin Case Rep

Author:

Ta An-Phuc¹^ORCID,Hsu Megan¹^ORCID,Iwamoto Satori¹

Affiliation:

1. California Northstate University College of Medicine, USA

Abstract

Sporadic or inherited deficiencies in the production or activity of the tumor suppressor P53 lead to Li-Fraumeni Syndrome (LFS), a multi-organ tumorigenic condition. Glioblastoma multiforme (GBM), a tumor that commonly presents with a median age of 64, has a higher chance of appearing in much younger patients who have LFS [9]. Since the implementation of the 2016 Toronto Protocol to increase cancer surveillance in LFS patients, three cases of LFS-GBM have been discussed [11-13]. Here, we report a case of LFS in an 18-year-old male who had a seizure due to a GBM that had evaded a full-body MRI six months prior. Furthermore, we discuss the potential quality of life (QOL) benefits of providing patients with a shorter brain MRI screening interval: better survival outcomes and peace of mind. Though there may be a rise in the financial cost with an increase in the number of MRI scans, the prevalence of aggressive tumors that must be treated early for a better prognosis warrants more frequent screening. Furthermore, we address the importance of expanding clinical knowledge on GBM in the LFS setting as well as addressing the benefits of the protocol through statistical studies.

Publisher

Asploro Open Access Publications

Subject

General Medicine

Reference13 articles.

1. Fang Z, Su Y, Sun H, Ge M, Qi Z, Hao C, Qian S, Ma X. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings. BMC Pediatr. 2021 Dec 27;21(1):588. [PMID: 34961499]

2. Wu X, Tian S, Liang B, Yang Q, Ng H, Wu S, Chang Q, Chen ZP. A young adult patient with Li-Fraumeni syndrome-associated glioblastoma: Case discussion and literature review. Glioma. 2020 Apr 1;3(2):71-75.

3. Stajkovska A, Mehandziska S, Rosalia R, Stavrevska M, Janevska M, Markovska M, Kungulovski I, Mitrev Z, Kungulovski G. A Pediatric Case of Glioblastoma Multiforme Associated With a Novel Germline p.His112CysfsTer9 Mutation in the MLH1 Gene Accompanied by a p.Arg283Cys Mutation in the TP53 Gene: A Case Report. Front Genet. 2019 Oct 22;10:952. [PMID: 31749828]

4. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008. [PMID: 20182602]

5. Consul N, Amini B, Ibarra-Rovira JJ, Blair KJ, Moseley TW, Taher A, Shah KB, Elsayes KM. Li-Fraumeni Syndrome and Whole-Body MRI Screening: Screening Guidelines, Imaging Features, and Impact on Patient Management. AJR Am J Roentgenol. 2021 Jan;216(1):252-63. [PMID: 33151095]